Jump to content
Powered by BIOPRO BW
  • BIOPRO BW
  • Healthcare industry
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
Healthcare industry Logo

Main navigation

  • Start page Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close Close
  • Databases

    Databases

    Close Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Heart surgery without a heart-lung machine - 18/11/2026 Medical illustration of a heart with an implanted ventricular assist device

    HeartGate: the safe gateway to the heart

    For patients with advanced heart failure, a mechanical heart pump can offer a life-saving alternative to heart transplants. As part of the HeartGate project, researchers at the University Medical Center Freiburg are developing an innovative implantation system to insert a heart pump directly into a beating heart.

    https://www.gesundheitsindustrie-bw.de/en/article/news/heartgate-safe-gateway-heart
  • Press release - 17/11/2026

    When Brake Cells Become Killer Cells: Double Honor for DKFZ Researcher Julius Michel

    Julius Michel, a postdoctoral researcher at the German Cancer Research Center, has received two awards: the Craig Tendler Award for Myeloma Research from the American Society of Hematology - awarded for the first time and accompanied by a $10,000 prize - as well as another award from the society.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/when-brake-cells-become-killer-cells-double-honor-dkfz-researcher-julius-michel
  • Press release - 12/11/2026

    DKFZ Sets Records for ERC Synergy Grants

    A historic success for the German Cancer Research Center (DKFZ): Four DKFZ researchers are receiving one of the prestigious ERC Synergy Grants this year—more than ever before at a single institution in a single funding round. Three of the four international research consortia are coordinated by the DKFZ. In total, the projects will receive approximately 44.5 million euros, of which about 13.7 million euros will go to the DKFZ.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/dkfz-sets-records-erc-synergy-grants
  • Press release - 11/11/2026

    Spine tumor surgery: Better preparation with a digital twin

    How can complex spinal tumor surgeries be planned and prepared more effectively in the future? As part of the IntelliSpine-Recon collaborative project, researchers will develop, among other innovations, a digital twin of the spine and a virtual training environment for surgeons. The junior research consortium, coordinated by the Heidelberg Faculty of Medicine at Heidelberg University, is being carried out in partnership with the KIT.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/spine-tumor-surgery-better-preparation-digital-twin
  • Press release - 09/11/2026

    Mirco Friedrich Receives the Peter and Traudl Engelhorn Foundation Award

    Mirco Julian Friedrich, a physician and cancer researcher at the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Research Institute, and Heidelberg University Hospital (UKHD), is being honored for his outstanding research on the aging immune system and the immune response to blood cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/mirco-friedrich-receives-peter-and-traudl-engelhorn-foundation-award
  • Press release - 02/11/2026

    Stem Cells in Deep Sleep as a Secret Reserve

    Researchers at the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have discovered a group of particularly long-lived blood stem cells in mice. These cells remain in a dormant state for an exceptionally long time while retaining their ability to generate new blood cells. This newly discovered cell population may be responsible for sustaining blood regeneration and immune defense throughout a mouse’s entire life.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/stem-cells-deep-sleep-secret-reserve
  • Press release - 29/10/2026

    New Approach Could Make Immunotherapy for Blood Cancer More Precise

    Researchers at the Faculty of Medicine – University of Freiburg have developed a new approach to specifically target an aggressive form of blood cancer while better sparing healthy immune cells. In what is known as T-cell acute lymphoblastic leukemia (T-ALL), cancer cells develop from the body’s own immune defense cells. This complicates treatment, as immunotherapies studied to date can also destroy healthy immune cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-approach-could-make-immunotherapy-blood-cancer-more-precise
  • Press release - 28/10/2026

    A Discovery in Freiburg Makes Cancer Immunotherapy Better Tolerated

    A discovery made in Freiburg opens up new treatment options for cancer patients worldwide: Researchers at the Medical Center – University of Freiburg have discovered how severe side effects of cancer immunotherapies can be alleviated using a specialized cell therapy involving treated white blood cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/discovery-freiburg-makes-cancer-immunotherapy-better-tolerated
  • Press release - 16/10/2026

    A new approach to osteoporosis treatment Disabling a bone formation inhibiting protein molecule

    How can the human body be stimulated to build more bone, thus helping those affected by osteoporosis? Researchers in Ulm have investigated the role played by the protein molecule Axl in this process. Their efforts were successful: in a study, they demonstrated that Axl inhibits bone formation – and that cells produce significantly more bone tissue when the molecule is blocked using medication. There are no discernible harmful side effects.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-approach-osteoporosis-treatment-disabling-bone-formation-inhibiting-protein-molecule
  • Press release - 06/10/2026

    Harnessing Synthetic Cellular Systems as Immune Cell Boosters

    How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based immunotherapies.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/harnessing-synthetic-cellular-systems-immune-cell-boosters
  • Press release - 05/10/2026

    A Matter of Quantity: A Universal Target for CAR-T Cells Against Cancer

    CAR-T cell therapies have proven successful in treating several types of blood and lymphoid cancers. However, their use in treating other tumors is significantly more challenging, in part because suitable target structures are lacking.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/matter-quantity-universal-target-car-t-cells-against-cancer-1
  • Press release - 05/10/2026

    A Matter of Quantity: A Universal Target for CAR-T Cells Against Cancer

    CAR-T cell therapies have proven successful in treating several types of blood and lymphoid cancers. However, their use in treating other tumors is significantly more challenging, in part because suitable target structures are lacking.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/matter-quantity-universal-target-car-t-cells-against-cancer
  • Press release - 05/10/2026

    How blood flow controls liver function

    The liver is organized into distinct zones in which liver cells perform different functions. The blood vessels of the liver play an important role in this spatial organization: the endothelial cells lining the vessels provide signals that instruct neighboring liver cells and help determine their function. But how do endothelial cells know which signals to produce?

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-blood-flow-controls-liver-function
  • Use of health data - 22/09/2026 Ein Bild in den Farben blau und grün, das in der Mitte den Kopf eines Babys zeigt. Darunter eine Karte mit einem Blutstropfen und Verschaltungen eines neuronalen Netzes einer KI.

    The digital twin – shaping the future of neonatal medicine

    Virtually every newborn undergoes routine screening shortly after birth to detect congenital disorders. These examinations have generated a unique wealth of data on early childhood development. However, for many years this valuable resource remained largely untapped. That all changed when researchers in Heidelberg started to use the data to develop a digital twin for newborns. Today, the technology is on the verge of entering clinical practice.

    https://www.gesundheitsindustrie-bw.de/en/article/news/digital-twin-shaping-future-neonatal-medicine
  • Press release - 17/09/2026

    New technique could make MRI more precise

    A team of researchers at the University of Stuttgart has developed a new method that could make MRI even more precise by eliminating “dead time,” a key limiting factor in the measurement process, thereby enabling the detection of signals that are lost using conventional methods. This method opens up new possibilities for medical diagnostics and non-destructive materials testing. The research team presents the new approach in Science Advances.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-technique-could-make-mri-more-precise
  • Press release - 08/09/2026

    Quality Over Quantity: New Insights into the Role of Specific CAR T Cells in Cancer Therapy

    CAR T-cell therapies are used successfully to treat certain blood cancers. However, while some patients respond even to low-dose treatment, others derive no benefit. Researchers from the Heidelberg Faculty of Medicine at Heidelberg University and the Berlin Institute of Health at Charité (BIH) investigated the reasons behind these differences in a collaborative research project.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/quality-over-quantity-new-insights-role-specific-car-t-cells-cancer-therapy
  • Press release - 01/09/2026

    Early Detection of COPD: A Study in Freiburg Investigates a New Treatment

    Coughing, phlegm, and shortness of breath can be early signs of COPC. In COPD, the airways are permanently narrowed, making it harder to breathe. The most significant risk factor is long-term smoking. The CHRONOS study conducted by the Department of Pneumology at the Medical Center – University of Freiburg provides evidence that changes in the lungs can already be detected before a standard pulmonary function test confirms the airway narrowing.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/early-detection-copd-study-freiburg-investigates-new-treatment
  • Press release - 13/08/2026

    PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

    Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/prame-specific-t-cell-therapy-adolescent-metastatic-kidney-tumor
  • Press release - 10/08/2026

    Immune Cells in Bone Marrow Cancer: Limited Defense Readiness

    A team led by researchers from the German Cancer Research Center, the HI-STEM* Stem Cell Institute, and Medical Clinic V at Heidelberg University Hospital has characterized T cells in the bone marrow in cases of multiple myeloma and acute myeloid leukemia: A specific group of tumor-reactive T cells can recognize and fight cancer cells, but is often not sufficiently activated. Nevertheless, the number of these cells influences the prognosis.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/immune-cells-bone-marrow-cancer-limited-defense-readiness
  • Press release - 07/08/2026

    Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

    Researchers from the Medical Faculty Heidelberg, the Medical Faculty Mannheim, and the Centre for Organismal Studies at Heidelberg University have launched a new research project investigating so-called dipeptides. The consortium aims to determine which dipeptides have the strongest protective effects and how they could be harnessed in future therapies for vascular and kidney diseases.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/can-protein-building-blocks-protect-against-vascular-and-kidney-damage
  • Press release - 31/07/2026

    New insights into Malaria research: How molecular tethers and Asynchronous replication drive parasite proliferation

    Researchers from Heidelberg University’s Faculty of Medicine, Harvard Medical School, and the German Cancer Research Center (DKFZ) have uncovered key mechanisms underlying the proliferation of the malaria parasite Plasmodium. The molecular processes that govern the formation of infectious daughter parasites and new nuclei are essential for parasite survival and may therefore represent targets for future antimalarial therapies.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-insights-malaria-research-how-molecular-tethers-and-asynchronous-replication-drive-parasite-proliferation
  • Press release - 20/07/2026

    Blood vessels guide immune cells to metastases

    It has long been suspected that endothelial cells play a key role in determining how the body’s immune system responds to tumors. Researchers at the DKFZ and the Medical Faculty Mannheim of Heidelberg University have now identified, in mouse studies, a specialized population of blood vessel lining endothelial cells that enable an effective immune defense against cancer metastases in the liver.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-vessels-guide-immune-cells-metastases
  • Press release - 16/07/2026

    New Findings on Acute Leukemias: Specific Mutations Provide Targets for More Targeted Therapies

    Researchers at the NCT Heidelberg and the German Cancer Research Center (DKFZ) have, for the first time, systematically determined how specific mutations promote acute myeloid leukemias. The results show why IDH1- and IDH2-mutated leukemias develop differently despite similar molecular mechanisms—and open up new approaches for diagnostics and targeted therapies.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-findings-acute-leukemias-specific-mutations-provide-targets-more-targeted-therapies
  • CRISPR base editing for tailored tumour treatment - 16/07/2026 Schematic illustration depicting the steps described in the text for generating CAR T cells.

    Targeted genetic manipulation of signal transduction pathways in CAR T cells enhances anti-tumour potency

    Chimeric antigen receptor (CAR) T cell therapy has emerged as a highly promising treatment modality but has so far been used almost exclusively for advanced haematologic malignancies. Researchers at the iFIT cluster of excellence in Tübingen have now used CRISPR base-editing technology to introduce precise point mutations into key signalling pathways of CAR T cells, significantly enhancing their long-term persistence and anti-tumour potency.

    https://www.gesundheitsindustrie-bw.de/en/article/news/targeted-genetic-manipulation-signal-transduction-pathways-car-t-cells-enhances-anti-tumour-potency
  • Press release - 14/07/2026

    Steering the Formulation of Engineered Tissue by Sound Waves

    With the aid of physical forces it is possible to actively steer the formation of engineered tissue. For example, sound waves can be used to create functional vascular networks with blood vessel-like structures in vitro. Scientists at the Center for Molecular Biology of Heidelberg University have demonstrated this through their methodology for acoustic manipulation.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/steering-formulation-engineered-tissue-sound-waves

Page 1 / 11

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 11
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2026
Website address: https://www.gesundheitsindustrie-bw.de/en/search